These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23849977)

  • 1. A pilot study of autologous CD34-depleted bone marrow mononuclear cell transplantation via the hepatic artery in five patients with liver failure.
    Park CH; Bae SH; Kim HY; Kim JK; Jung ES; Chun HJ; Song MJ; Lee SE; Cho SG; Lee JW; Choi JY; Yoon SK; Han NI; Lee YS
    Cytotherapy; 2013 Dec; 15(12):1571-9. PubMed ID: 23849977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study.
    Khan AA; Parveen N; Mahaboob VS; Rajendraprasad A; Ravindraprakash HR; Venkateswarlu J; Rao SG; Narusu ML; Khaja MN; Pramila R; Habeeb A; Habibullah CM
    Transplant Proc; 2008 May; 40(4):1140-4. PubMed ID: 18555134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy.
    Terai S; Ishikawa T; Omori K; Aoyama K; Marumoto Y; Urata Y; Yokoyama Y; Uchida K; Yamasaki T; Fujii Y; Okita K; Sakaida I
    Stem Cells; 2006 Oct; 24(10):2292-8. PubMed ID: 16778155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term follow-up on emergent intracoronary autologous bone marrow mononuclear cell transplantation for acute inferior-wall myocardial infarction].
    Huang RC; Yao K; Zou YZ; Ge L; Qian JY; Yang J; Yang S; Niu YH; Li YL; Zhang YQ; Zhang F; Xu SK; Zhang SH; Sun AJ; Ge JB
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1107-10. PubMed ID: 16796836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis.
    Liao X; AnCheng JY; Zhou QJ; Liao C
    Hepatogastroenterology; 2013 May; 60(123):406-9. PubMed ID: 23178469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow and Peripheral Blood Mononuclear Cell Phenotype Changes after Cultivation and Autologous Infusion in Patients with Primary Biliary Cholangitis.
    Saipiyeva D; Askarov M; Jafari N; Zhankina R; Heath PR; Kozina L; Boltanova A; Omarbekov A; Ilyassov N; Tuganbekov T; Mussin NM; Kaliyev AA; Sultangereyev Y; Rahmanifar F; Mahdipour M; Bakhshalizadeh S; Shirazi R; Tanideh N; Tamadon A
    Iran J Med Sci; 2024 Sep; 49(9):559-572. PubMed ID: 39371380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous bone marrow stem cell transplantation for treatment terminal liver diseases].
    Pan XN; Shen JK; Zhuang YP; Chen XL; Li YX; Chen LJ; Yang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1207-9. PubMed ID: 18676264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.
    Peng L; Xie DY; Lin BL; Liu J; Zhu HP; Xie C; Zheng YB; Gao ZL
    Hepatology; 2011 Sep; 54(3):820-8. PubMed ID: 21608000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study.
    Lyra AC; Soares MB; da Silva LF; Braga EL; Oliveira SA; Fortes MF; Silva AG; Brustolim D; Genser B; Dos Santos RR; Lyra LG
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):33-42. PubMed ID: 19654548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous bone marrow cell infusion therapy for liver cirrhosis--now and future].
    Sakaida I
    Rinsho Byori; 2011 Dec; 59(12):1092-8. PubMed ID: 22338911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow.
    Tanimoto H; Terai S; Taro T; Murata Y; Fujisawa K; Yamamoto N; Sakaida I
    Cell Tissue Res; 2013 Dec; 354(3):717-28. PubMed ID: 24104560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters.
    Malyar NM; Radtke S; Malyar K; Arjumand J; Horn PA; Kröger K; Freisinger E; Reinecke H; Giebel B; Brock FE
    Cytotherapy; 2014 Sep; 16(9):1270-9. PubMed ID: 24972744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells.
    Terai S; Takami T; Yamamoto N; Fujisawa K; Ishikawa T; Urata Y; Tanimoto H; Iwamoto T; Mizunaga Y; Matsuda T; Oono T; Marumoto M; Burganova G; Fernando Quintanilha L; Hidaka I; Marumoto Y; Saeki I; Uchida K; Yamasaki T; Tani K; Taura Y; Fujii Y; Nishina H; Okita K; Sakaida I
    Tissue Eng Part B Rev; 2014 Jun; 20(3):206-10. PubMed ID: 24450831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
    Capiod JC; Tournois C; Vitry F; Sevestre MA; Daliphard S; Reix T; Nguyen P; Lefrère JJ; Pignon B
    Vox Sang; 2009 Apr; 96(3):256-65. PubMed ID: 19207166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous stem cell transplantation for expansion of remnant liver volume with extensive hepatectomy.
    Han HS; Ahn KS; Cho JY; Yoon YS; Yoon CJ; Park KU; Min SK; Lee HK; Ryu KH
    Hepatogastroenterology; 2014; 61(129):156-61. PubMed ID: 24895813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell therapy in chronic liver disease.
    Takami T; Terai S; Sakaida I
    Curr Opin Gastroenterol; 2012 May; 28(3):203-8. PubMed ID: 22395569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study.
    Jang YO; Kim YJ; Baik SK; Kim MY; Eom YW; Cho MY; Park HJ; Park SY; Kim BR; Kim JW; Soo Kim H; Kwon SO; Choi EH; Kim YM
    Liver Int; 2014 Jan; 34(1):33-41. PubMed ID: 23782511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Observation on the safety: clinical trail on intracoronary autologous bone marrow mononuclear cells transplantation for acute myocardial infarction].
    Yao K; Huang RC; Ge L; Qian JY; Li YL; Xu SK; Zhang F; Zhang YQ; Niu YH; Shi JH; Zhang SH; Fan B; Wang QB; Sun AJ; Zou YZ; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jul; 34(7):577-81. PubMed ID: 17081355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of autologous bone marrow mononuclear cell transplantation in decompensated liver cirrhosis.
    Bai YQ; Yang YX; Yang YG; Ding SZ; Jin FL; Cao MB; Zhang YR; Zhang BY
    World J Gastroenterol; 2014 Jul; 20(26):8660-6. PubMed ID: 25024623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation.
    Hernández P; Cortina L; Artaza H; Pol N; Lam RM; Dorticós E; Macías C; Hernández C; del Valle L; Blanco A; Martínez A; Díaz F
    Atherosclerosis; 2007 Oct; 194(2):e52-6. PubMed ID: 16982058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.